breast cancer risk assessment Archives

Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…

Digital Health Awards 2025 winners revealed

Navigating Clinical Trials: Physicians Face Major Hurdles in Accessing Innovative Treatments

Methodist Le Bonheur Selects Ensemble as Strategic RCM Partner

Commercialization of medical artificial intelligence technologies: challenges and opportunities

Tag: breast cancer risk assessment

Revolutionary AI Merger Transforms Breast Cancer Detection

Digital Health Awards 2025 winners revealed

Navigating Clinical Trials: Physicians Face Major Hurdles in Accessing Innovative Treatments

Methodist Le Bonheur Selects Ensemble as Strategic RCM Partner

Commercialization of medical artificial intelligence technologies: challenges and opportunities

Large language model integrations in cancer decision-making: a systematic review and meta-analysis

Evaluation of an integrated digital and mobile intervention to improve outcomes for patients with moderate to severe COPD

News 7/18/25

The Impact of an Adaptive mHealth Intervention on Improving Patient-Provider Health Care Communication: Secondary Analysis of the DIAMANTE Trial

A mixed methods formative evaluation of the United Kingdom National Health Service Artificial Intelligence Lab

Negative control-calibrated difference-in-difference analyses: addressing unmeasured confounding in RWD with application to racial/ethnic differences

MediFormatica

News Aggregator